Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Redox processes in neurodegenerative disease involving reactive oxygen species.
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
Dietary interventions for multiple sclerosis.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis.
Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia.
Neuropathology of multiple system atrophy: New thoughts about pathogenesis.
Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Relationship between Damage to the Cerebellar Peduncles and Clinical Disability in Multiple Sclerosis.
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Both positive and negative effects on immune responses by expression of a second class II MHC molecule.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosis.
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Improving communication with multiple sclerosis patients.

Pages